Description
Also known as:
- GBinsight Dyslipidemia and ASCVD Comprehensive Test
This next-generation sequencing (NGS)-based genetic test analyzes 140 genes relevant to atherosclerotic cardiovascular disease risk and monogenic and polygenic lipid disorders, including high cholesterol, high triglycerides, low and high HDL, and high Lp(a), endothelial dysfunction and statin-induced muscle pain. NGS allows for the genetic analysis of single nucleotide variants, short insertion/deletions and large genomic deletions/duplications. More details
Some of the genes tested include (but are not limited to):
- LPA
- APOA5
- LPL
- PCSK9
- LDLR
- APOB
- SCARB1
- APOE
See “Genes” tab on GBinsight page for a full list of genes tested and additional information.
This test requires a test kit be shipped, please ensure a valid address is provided at checkout so the test kit can be received. See GBinsight landing page for more information.
